DE60318327D1 - Verwendung von resveratrol zur herstellung eines arzneimittels zur behandlung von grippe - Google Patents
Verwendung von resveratrol zur herstellung eines arzneimittels zur behandlung von grippeInfo
- Publication number
- DE60318327D1 DE60318327D1 DE60318327T DE60318327T DE60318327D1 DE 60318327 D1 DE60318327 D1 DE 60318327D1 DE 60318327 T DE60318327 T DE 60318327T DE 60318327 T DE60318327 T DE 60318327T DE 60318327 D1 DE60318327 D1 DE 60318327D1
- Authority
- DE
- Germany
- Prior art keywords
- resveratrol
- medicament
- manufacture
- fluid
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM20020562 | 2002-11-06 | ||
| IT000562A ITRM20020562A1 (it) | 2002-11-06 | 2002-11-06 | Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza. |
| PCT/IT2003/000626 WO2004041260A1 (en) | 2002-11-06 | 2003-10-14 | Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60318327D1 true DE60318327D1 (de) | 2008-02-07 |
| DE60318327T2 DE60318327T2 (de) | 2008-12-18 |
Family
ID=32310188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60318327T Expired - Lifetime DE60318327T2 (de) | 2002-11-06 | 2003-10-14 | Verwendung von resveratrol zur herstellung eines arzneimittels zur behandlung von grippe |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8431617B2 (de) |
| EP (1) | EP1567137B1 (de) |
| JP (1) | JP4589118B2 (de) |
| KR (1) | KR101060331B1 (de) |
| AR (1) | AR041891A1 (de) |
| AT (1) | ATE381929T1 (de) |
| AU (1) | AU2003279551A1 (de) |
| CA (1) | CA2504872C (de) |
| CY (1) | CY1107302T1 (de) |
| DE (1) | DE60318327T2 (de) |
| DK (1) | DK1567137T3 (de) |
| ES (1) | ES2295660T3 (de) |
| IT (1) | ITRM20020562A1 (de) |
| MX (1) | MXPA05004628A (de) |
| PL (1) | PL217628B1 (de) |
| PT (1) | PT1567137E (de) |
| TW (1) | TWI337863B (de) |
| WO (1) | WO2004041260A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080260690A1 (en) * | 2005-11-18 | 2008-10-23 | Ares Trading S.A. | Interferon in Influenza |
| EP2268272A2 (de) * | 2008-03-06 | 2011-01-05 | Mount Sinai School of Medicine of New York University | Verbindungen zur modulation der replikation von einstrangigen minus-rna-viren und verwendungen davon |
| AU2009313657A1 (en) * | 2008-11-04 | 2010-05-14 | Metaproteomics, Llc | Phytochemical compositions and methods for activating AMP-kinase |
| CA2744947A1 (en) * | 2008-12-19 | 2010-10-28 | The Regents Of The University Of California | Use of epidermal growth factor inhibitors in the treatment of viral infection |
| KR100950445B1 (ko) | 2009-10-26 | 2010-04-02 | 주식회사 중앙백신연구소 | 감초로부터 얻은 조류, 돼지 인플루엔자 및 신종플루에 대한 항바이러스제 |
| US9096585B2 (en) | 2010-05-28 | 2015-08-04 | Icahn School Of Medicine At Mount Sinai | Antiviral compounds and uses thereof |
| EP2760447A4 (de) * | 2011-09-30 | 2015-10-21 | Univ Vanderbilt | Antivirale behandlungen mit phospholipase-d-inhibitoren |
| EP2952209B1 (de) | 2014-06-04 | 2018-03-28 | Alfasigma S.p.A. | Homogene Formulierungen mit mehrfach ungesättigten Omega-3-Fettsäuren (n-3 PUFA) und Resveratrol zur oralen Verabreichung |
| ES2615630T3 (es) | 2014-06-04 | 2017-06-07 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Formulaciones sólidas que contienen resveratrol y ácidos grasos poliinsaturados omega-3 (n-3 PUFA) |
| EP3120842A1 (de) | 2015-07-20 | 2017-01-25 | Opterion Health AG | Peritoneale therapeutische flüssigkeit |
| KR20170039456A (ko) | 2015-10-01 | 2017-04-11 | 동아대학교 산학협력단 | 오동나무로부터 추출한 ｃ-제라닐플라보노이드계 물질을 포함하는 인플루엔자 예방 및 치료용 약학 조성물 |
| JP2018024592A (ja) * | 2016-08-09 | 2018-02-15 | 株式会社ブレインヘルス | 抗生物質含有組成物 |
| CN108893558B (zh) * | 2018-05-24 | 2022-04-05 | 江苏海宏制药有限公司 | 一种桑木液原液抗病毒实验方法以及装置 |
| EP4132277A1 (de) | 2020-04-05 | 2023-02-15 | Mong, Michael | Systeme und verfahren zur behandlung des coronavirus |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2778337B1 (fr) | 1998-05-05 | 2001-08-31 | Inst Nat Sante Rech Med | Antagonistes des ligands du recepteur des arylhydrocarbures |
| PE20010540A1 (es) | 1999-07-30 | 2001-05-15 | Procter & Gamble | Composicion de fitoalexinas estilbenicas util para la profilaxis y tratamiento de sintomas asociados con el resfriado y enfermedades similares a la influenza |
| DE60015568D1 (de) | 1999-08-13 | 2004-12-09 | Univ Maryland Biotech Inst | Zusammensetzungen zur behandlung von viralen infektionen und verfahren dafür |
-
2002
- 2002-11-06 IT IT000562A patent/ITRM20020562A1/it unknown
-
2003
- 2003-10-14 WO PCT/IT2003/000626 patent/WO2004041260A1/en active IP Right Grant
- 2003-10-14 PL PL377557A patent/PL217628B1/pl unknown
- 2003-10-14 JP JP2004549541A patent/JP4589118B2/ja not_active Expired - Lifetime
- 2003-10-14 AT AT03772659T patent/ATE381929T1/de active
- 2003-10-14 PT PT03772659T patent/PT1567137E/pt unknown
- 2003-10-14 ES ES03772659T patent/ES2295660T3/es not_active Expired - Lifetime
- 2003-10-14 KR KR1020057007230A patent/KR101060331B1/ko active IP Right Grant
- 2003-10-14 DE DE60318327T patent/DE60318327T2/de not_active Expired - Lifetime
- 2003-10-14 EP EP03772659A patent/EP1567137B1/de not_active Expired - Lifetime
- 2003-10-14 US US10/533,942 patent/US8431617B2/en active Active
- 2003-10-14 DK DK03772659T patent/DK1567137T3/da active
- 2003-10-14 MX MXPA05004628A patent/MXPA05004628A/es active IP Right Grant
- 2003-10-14 AU AU2003279551A patent/AU2003279551A1/en not_active Abandoned
- 2003-10-14 CA CA2504872A patent/CA2504872C/en not_active Expired - Lifetime
- 2003-10-27 TW TW092129780A patent/TWI337863B/zh not_active IP Right Cessation
- 2003-11-05 AR ARP030104047A patent/AR041891A1/es unknown
-
2008
- 2008-03-12 CY CY20081100281T patent/CY1107302T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR101060331B1 (ko) | 2011-08-30 |
| JP4589118B2 (ja) | 2010-12-01 |
| DE60318327T2 (de) | 2008-12-18 |
| EP1567137B1 (de) | 2007-12-26 |
| ES2295660T3 (es) | 2008-04-16 |
| EP1567137A1 (de) | 2005-08-31 |
| ATE381929T1 (de) | 2008-01-15 |
| CY1107302T1 (el) | 2012-11-21 |
| AR041891A1 (es) | 2005-06-01 |
| AU2003279551A1 (en) | 2004-06-07 |
| PT1567137E (pt) | 2008-02-19 |
| KR20050071627A (ko) | 2005-07-07 |
| PL217628B1 (pl) | 2014-08-29 |
| TWI337863B (en) | 2011-03-01 |
| CA2504872C (en) | 2011-07-05 |
| CA2504872A1 (en) | 2004-05-21 |
| WO2004041260A1 (en) | 2004-05-21 |
| DK1567137T3 (da) | 2008-04-28 |
| PL377557A1 (pl) | 2006-02-06 |
| TW200501935A (en) | 2005-01-16 |
| US20050239906A1 (en) | 2005-10-27 |
| ITRM20020562A1 (it) | 2004-05-07 |
| US8431617B2 (en) | 2013-04-30 |
| JP2006507295A (ja) | 2006-03-02 |
| MXPA05004628A (es) | 2005-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60320007D1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
| DE60230425D1 (de) | Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege | |
| DE602004029580D1 (de) | Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen | |
| DE602004020072D1 (de) | 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen | |
| DE50209278D1 (de) | Vorrichtung zur Behandlung einer medizinischen Flüssigkeit | |
| ATE410430T1 (de) | 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose | |
| DE60328476D1 (de) | Medizinisches ballonsystem zur behandlung von adipositas | |
| NO20033594D0 (no) | Fenetanolamin-derivater for behandling av luftveissykdommer | |
| DE602005017503D1 (de) | Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen | |
| EA200601837A1 (ru) | Бензоксазины для лечения заболеваний дыхательных путей | |
| DE60318327D1 (de) | Verwendung von resveratrol zur herstellung eines arzneimittels zur behandlung von grippe | |
| DE602004029465D1 (de) | Externes Präparat zur Behandlung von Fusspilz | |
| NO20045554L (no) | Fremgangsmate for behandling av diabetes | |
| ATE510536T1 (de) | Verwendung von 2,5-dihydroxybenzol-derivaten zur behandlung von reaktiven gewebeerkrankungen | |
| DE602005019341D1 (de) | System zur Behandlung von Sterilisationskassetten mit visuellem Dual-Kode Leser | |
| DE602006003094D1 (de) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit | |
| DE502005002324D1 (de) | Reaktor zur behandlung hochviskoser kunststoffschmelzen | |
| DE60236743D1 (de) | Zur behandlung androgenabhängiger krankheiten | |
| DE50209948D1 (de) | Verwendung von Scopinester Derivaten zur Herstellung von Arzneimitteln | |
| ATE482707T1 (de) | 1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen | |
| DE502004004324D1 (de) | Maschine zur Behandlung eines Gleises | |
| DE602005000442D1 (de) | Verwendung von alpha-1-Antitrypsin zur Herstellung eines Medikaments zur Behandlung von Fibromyalgie | |
| DE60200160D1 (de) | Verwendung von Cilobradine oder pharmazeutisch akzeptablen Salze zur Behandlung oder Prävention von Herzversagen | |
| DE602006018822D1 (de) | Verwendung des Agomelatins zur Herstellung eines Medikamentes zur Behandlung der bipolaren Erkrankungen | |
| DE602004026067D1 (de) | Gerät zur Behandlung von Füßen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8381 | Inventor (new situation) |
Inventor name: GARACI, ENRICO, I-00040 POMEZIA, IT Inventor name: PALAMARA, ANNA T., I-00040 POMEZIA, IT |
|
| 8364 | No opposition during term of opposition |